NEW YORK — GeneDx said on Wednesday that it has signed an agreement to offer genomic services to neonatal intensive care units associated with physician services firm Pediatrix Medical Group.
Under the terms of the deal, GeneDx will provide next-generation sequencing in support of clinical diagnosis in neonatal intensive care units staffed with Pediatrix-affiliated neonatologists across the US. GeneDx said that initial offerings will include whole-exome and whole-genome sequencing, as well as genomic support services, under the brand Detect Genomix.